Trial · NCT04596995
Adverse events26
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 26 of 26
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Platelet count decreased | Investigations | Rozanolixizumab | 1 | 43 | 1 |
| serious | Leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Rozanolixizumab | 1 | 43 | 1 |
| serious | Uterine haemorrhage | Reproductive system and breast disorders | Rozanolixizumab | 2 | 43 | 2 |
| serious | Purpura | Skin and subcutaneous tissue disorders | Rozanolixizumab | 1 | 43 | 1 |
| serious | Skin haemorrhage | Skin and subcutaneous tissue disorders | Rozanolixizumab | 1 | 43 | 2 |
| serious | Haemorrhage | Vascular disorders | Rozanolixizumab | 1 | 43 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04596995/events?page=2